Skip to content

An open randomised study to assess the efficacy of gatifloxacin versus azithromycin for the treatment of uncomplicated typhoid fever

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN67946944
Enrollment
Unknown
Registered
2005-07-22
Start date
2005-10-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Typhoid fever Infections and Infestations Typhoid fever

Interventions

An open randomised two-way comparison of gatifloxacin (10 mg/kg/day) versus azithromycin (20 mg/kg/day) for seven days for the treatment of symptomatic uncomplicated typhoid fever.

Sponsors

University of Oxford (UK)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients will be eligible if they have suspected or culture proven enteric fever provided: 1. They give fully informed consent 2. They are not obtunded not jaundiced 3. There are no signs of gastrointestinal (GI) bleeding or any other evidence of severity (see below) 4. No history of hypersensitivity to either of the trial drugs 5. No treatment with a quinolone or 3rd generation cephalosporin or macrolide within one week of hospital admission 6. They are not pregnant

Exclusion criteria

Exclusion criteria: 1. Pregnancy or lactation 2. Any signs of symptoms of severe disease 3. No informed consent

Design outcomes

Primary

MeasureTime frame
Fever Clearance Time.

Secondary

MeasureTime frame
Clinical and Microbiological Failure.

Countries

Viet Nam

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Apr 5, 2026